Viswam S. Nair, MD MS

Pulmonologist

Instructor, Medicine - Pulmonary & Critical Care Medicine Instructor (By courtesy), Radiology - General Radiology
4.6 out of 5
40 Patient Ratings
2 Patient Comments

Chest Clinic

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-725-7061
Learn More About the Clinic » Getting Here » Make An Appointment

Lung Nodule Surveillance and Cancer Detection Program

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-725-7061
Learn More About the Clinic » Getting Here » Make An Appointment

Professional Education

Fellowship: Stanford University Division of PCCM (2010) CA

Residency: Santa Clara Valley Medical Center (2007) CA

Medical Education: Ohio State University (2004) OH

Board Certification: Critical Care Medicine, American Board of Internal Medicine (2010)

Bachelor of Arts, University of Pennsylvania, Chemistry (1998)

Masters of Science, Stanford University, Clinical Epidemiology (2011)

Board Certification: Internal Medicine, American Board of Internal Medicine (2007)

Board Certification: Pulmonary Disease, American Board of Internal Medicine (2009)

Board Certification, Critical Care Medicine, American Board of Internal Medicine (2010)

Honors & Awards

Loan Repayment Program "In vivo and In vitro diagnostics to improve lung cancer care", NIH NCI (10/13-10/15)

In vivo and in vitro diagnostics for assessing the lung nodule, LUNGevity Foundation Career Development Award (07/12-07/15)

An analysis of early-stage NSCLC transcriptomics across varying FDG uptake levels on PET imaging, Lung Cancer Research Foundation (11/10-11/11)

PET-FDG uptake, gene expression and outcome in stage I resected lung adenocarcinoma, The CHEST Foundation, Clinical Research Award (07/09-07/10)

Administrative Appointments

Assistant Director, Lung Cancer Screening Program, Stanford (2014 - Present)

Co-Director, Lung Stanford Nodule Assessment Program (Lung-SNAP) (2013 - Present)

Associate Member, Canary Center at Stanford for Cancer Early Detection (2013 - Present)

Patient Ratings and Comments

4.7

Friendliness

4.5

Recommended to others

4.6

Explanations

4.6

Listens

4.7

Includes you in decisions

4.7

Clear Communication

4.6

Confidence in your doctor

4.3

Wait times

SHC Patient, Nov 2014

Dr. Nair spent quality time and explained and verified all.

SHC Patient, Apr 2014

Excellent.

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Circulating Tumor Microemboli Diagnostics for Patients with Non-Small-Cell Lung Cancer
Carlsson, A., Nair, V. S., Luttgen, M. S., Keu, K. V., Horng, G., & Gambhir, S. S. (2014). Circulating Tumor Microemboli Diagnostics for Patients with Non-Small-Cell Lung Cancer. JOURNAL OF THORACIC ONCOLOGY, 9(8), 1111-1119.

Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies
Nair, V. S., Pritchard, C. C., Tewari, M., & Ioannidis, J. Pa. (2014). Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies. AMERICAN JOURNAL OF EPIDEMIOLOGY, 180(2), 140-152.

NF-kappa B protein expression associates with F-18-FDG PET tumor uptake in non-small cell lung cancer: A radiogenomics validation study to understand tumor metabolism
Nair, V. S., Gevaert, O., Davidzon, G., Plevritis, S. K., & West, R. (2014). NF-kappa B protein expression associates with F-18-FDG PET tumor uptake in non-small cell lung cancer: A radiogenomics validation study to understand tumor metabolism. LUNG CANCER, 83(2), 189-196.

A Dominant Adenocarcinoma With Multifocal Ground Glass Lesions Does Not Behave as Advanced Disease
Gu, B., Burt, B. M., Merritt, R. E., Stephanie, S., Nair, V., & Shrager, J. B. (2013). A Dominant Adenocarcinoma With Multifocal Ground Glass Lesions Does Not Behave as Advanced Disease. ANNALS OF THORACIC SURGERY, 96(2), 411-418.

An Observational Study of Circulating Tumor Cells and F-18-FDG PET Uptake in Patients with Treatment-Naive Non-Small Cell Lung Cancer
Nair, V. S., Keu, K. V., Luttgen, M. S., Kolatkar, A., Vasanawala, M., & Kuhn, P. (2013). An Observational Study of Circulating Tumor Cells and F-18-FDG PET Uptake in Patients with Treatment-Naive Non-Small Cell Lung Cancer. PLOS ONE, 8(7).

Circulating tumour cells in early breast cancer
Nair, V. S., Keu, K. V., Kuhn, P., & Gambhir, S. S. (2012). Circulating tumour cells in early breast cancer. LANCET ONCOLOGY, 13(9), E370-E371.

Prognostic PET F-18-FDG Uptake Imaging Features Are Associated with Major Oncogenomic Alterations in Patients with Resected Non-Small Cell Lung Cancer
Nair, V. S., Gevaert, O., Davidzon, G., Napel, S., Graves, E. E., & Plevritis, S. K. (2012). Prognostic PET F-18-FDG Uptake Imaging Features Are Associated with Major Oncogenomic Alterations in Patients with Resected Non-Small Cell Lung Cancer. CANCER RESEARCH, 72(15), 3725-3734.

Clinical Outcome Prediction by MicroRNAs in Human Cancer: A Systematic Review
Nair, V. S., Maeda, L. S., & Ioannidis, J. Pa. (2012). Clinical Outcome Prediction by MicroRNAs in Human Cancer: A Systematic Review. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 104(7), 528-540.

Fluorodeoxyglucose-PET Scanning in the Diagnosis of Pleural Disease
Nair, V. S. (2011). Fluorodeoxyglucose-PET Scanning in the Diagnosis of Pleural Disease. CHEST, 139(4), 966-967.

PET Scan F-18-Fluorodeoxyglucose Uptake and Prognosis in Patients With Resected Clinical Stage IA Non-small Cell Lung Cancer
Nair, V. S., Barnett, P. G., Ananth, L., & Gould, M. K. (2010). PET Scan F-18-Fluorodeoxyglucose Uptake and Prognosis in Patients With Resected Clinical Stage IA Non-small Cell Lung Cancer. CHEST, 137(5), 1150-1156.

Management of Lung Nodules Detected by Volume CT Scanning
Nair, V. S. (2010). Management of Lung Nodules Detected by Volume CT Scanning. NEW ENGLAND JOURNAL OF MEDICINE, 362(8), 757-757.

Positron Emission Tomography F-18-Fluorodeoxyglucose Uptake and Prognosis in Patients with Surgically Treated, Stage I Non-small Cell Lung Cancer: A Systematic Review
Nair, V. S., Krupitskaya, Y., & Gould, M. K. (2009). Positron Emission Tomography F-18-Fluorodeoxyglucose Uptake and Prognosis in Patients with Surgically Treated, Stage I Non-small Cell Lung Cancer: A Systematic Review. JOURNAL OF THORACIC ONCOLOGY, 4(12), 1473-1479.

4.6 out of 5
40 Patient Ratings
2 Patient Comments

SHC Patient, Nov 2014

Dr. Nair spent quality time and explained and verified all.

SHC Patient, Apr 2014

Excellent.